
About
aMoon is a global HealthTech and Life Sciences investment fund based in Israel. As Israel’s largest HealthTech fund, with $1.1 billion AUM, we partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare.Together with our portfolio companies, we work tirelessly to advance solutions that will help people live healthier, better lives.We harness our unique team of over 50 scientists, physicians and entrepreneurs and our global network of investors and industry leaders to build bridges between our portfolio companies and global tech, finance and medical research hubs to help entrepreneurs turn their vision into reality.Through our Velocity Fund we invest in companies pursuing disruptive, cutting-edge technologies as early as venture formation through Series A. Our Growth Fund invests in later-stage companies that are either generating revenue in growth rounds, pre-IPO rounds or in pivotal clinical trials.
Sector Focus
Life Sciences
Cancer
Therapeutics
Biotech
Personalized Treatment
Healthcare
Drug Discovery
Antibody
Immunology
Data
Series Focus
Seed
Series A
Series B
Series C
Cheque Size
$10.0M - $50.0M
Score Breakdown
68Deal Activity
69Track Record
54Visibility
45Profile
100Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What type of investor is aMoon?
aMoon is a global HealthTech and Life Sciences investment fund based in Israel. As Israel’s largest HealthTech fund, with $1.1 billion AUM, we partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare.Together with our portfolio companies, we work tirelessly to advance solutions that will help people live healthier, better lives.We harness our…
What kind of firm is aMoon?
aMoon is a Venture Capital.
What is aMoon's assets under management?
aMoon manages approximately $1.3B in assets.
Where is aMoon based?
aMoon is based in Israel.
What sectors does aMoon focus on?
aMoon focuses on Life Sciences, Cancer, Therapeutics, Biotech.
Similar Investors
